Literature DB >> 18374523

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats.

E Pereverzeva1, I Treschalin, D Bodyagin, O Maksimenko, J Kreuter, S Gelperina.   

Abstract

A comparative toxicological study of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles coated with polysorbate 80 was performed in male and female Wistar rats. The drug substance was used as a reference formulation. The formulations were injected intravenously at a therapeutic dose of 6 mg/kg administered either as a single injection or in form of four weekly injections. The animals were followed up for 4 and 40 days (single injection) or 25 and 61 days (multiple injections) for assessment of the dynamics of body weight, hematological parameters, blood biochemical parameters, and urinalysis. Pathomorphological evaluation included macroscopic evaluation and weight measurement of the internal organs. The heart, lung, spleen, testes, and liver were also subjected to the histological evaluation. The overall result of this study suggests that the surfactant-coated nanoparticle formulation of doxorubicin has a favorable toxicological profile. Specifically, this formulation displays a considerably reduced cardio- and testicular toxicity, as compared to a free drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374523     DOI: 10.1016/j.toxlet.2008.01.020

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  9 in total

1.  In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles.

Authors:  Juliana M Chan; June-Wha Rhee; Chester L Drum; Roderick T Bronson; Gershon Golomb; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-15       Impact factor: 11.205

Review 2.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

3.  Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier.

Authors:  Kiran Ramanlal Chaudhari; Mukesh Ukawala; Arehalli S Manjappa; Abhinesh Kumar; Piyush Kishor Mundada; Anil Kumar Mishra; Rashi Mathur; Jukka Mönkkönen; Rayasa S Ramchandra Murthy
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

Review 4.  Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.

Authors:  Catherine DeMarino; Angela Schwab; Michelle Pleet; Allison Mathiesen; Joel Friedman; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-02       Impact factor: 4.147

5.  Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.

Authors:  Consolación Melguizo; Laura Cabeza; Jose Prados; Raúl Ortiz; Octavio Caba; Ana R Rama; Ángel V Delgado; José L Arias
Journal:  Drug Des Devel Ther       Date:  2015-12-14       Impact factor: 4.162

6.  Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with Doxorubicin.

Authors:  Tatyana Kovshova; Nadezhda Osipova; Anna Alekseeva; Julia Malinovskaya; Alexey Belov; Andrey Budko; Galina Pavlova; Olga Maksimenko; Shakti Nagpal; Svenja Braner; Harshvardhan Modh; Vadim Balabanyan; Matthias G Wacker; Svetlana Gelperina
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

7.  Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization.

Authors:  Yu Nie; Li Ji; Hong Ding; Li Xie; Li Li; Bin He; Yao Wu; Zhongwei Gu
Journal:  Theranostics       Date:  2012-11-13       Impact factor: 11.556

8.  Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.

Authors:  Tangjian Cheng; Jinjian Liu; Jie Ren; Fan Huang; Hanlin Ou; Yuxun Ding; Yumin Zhang; Rujiang Ma; Yingli An; Jianfeng Liu; Linqi Shi
Journal:  Theranostics       Date:  2016-06-06       Impact factor: 11.556

9.  Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.

Authors:  Yunfang Zhou; Shuanghu Wang; Xuhua Ying; Yifan Wang; Peiwu Geng; Aiping Deng; Zhihong Yu
Journal:  Int J Nanomedicine       Date:  2017-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.